Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-02-19 @ 1:42 AM
Study NCT ID:
NCT06709859
Status:
RECRUITING
Last Update Posted:
2025-07-17
First Post:
2024-11-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC
Sponsor:
Organization: